| Cas No.: | 4051-59-6 |
| Chemical Name: | 2,2'-(1,4-Phenylene)bis[4,5-diphenyl-1H-imidazole] |
| Synonyms: | MSX-130; MSX 130; MSX130 |
| SMILES: | C1(C2=NC(C3=CC=CC=C3)=C(C4=CC=CC=C4)N2)=CC=C(C5=NC(C6=CC=CC=C6)=C(C7=CC=CC=C7)N5)C=C1 |
| Formula: | C36H26N4 |
| M.Wt: | 514.21 |
| Purity: | >98% |
| Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Description: | MSX-130 is a CXCR4 antagonist. MSX-130 inhibits cancer metastasis[1]. |
| Target: | CXCR4 |
| In Vitro: | The C-X-C chemokine receptor-4 (CXCR4) is a seven trans-membrane G-protein coupled receptor (GPCR) classified as a member of the family I GPCR or rhodopsin-like GPCR family. CXCR4 plays an important role in cancer metastasis, regulation of stem cell trafficking, and neovascularization[1]. |
| References: | [1]. Zhan W, et al. Discovery of small molecule CXCR4 antagonists. J Med Chem. 2007 Nov 15;50(23):5655-64. |

To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
